Nautilus Biotechnolgy, Inc. Common Stock (NAUT) Stock Price

NAUTStock

$0.88+24.86%52W

Market Cap$112.15M

P/E—

PEG Ratio—

Div yield—

Beta0.76

NAUT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-78.59%

Price vs S&P 500 (4W)-30.11%

VGM Score44.50

NAUT Earnings Surprise History

Q2 25-0.12est. -0.14

Q3 25-0.11est. -0.15

Q4 25-0.11est. -0.14

Q1 26-0.12est. -0.14

Q2 26-0.11est. -0.14

NAUT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.25

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.88
AAgilent Technologies Inc.	D	C	B	$154.77
WATWaters Corp	D	C	B	$414.44
ILMNIllumina Inc	D	D	A	$224.99
MTDMettler-Toledo International	D	C	B	$1402.25
RVTYRevvity, Inc.	C	D	B	$124.84
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$390.34
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
AVTRAvantor, Inc.	B	F	A	$14.42
BRKRBruker Corporation	D	D	B	$56.85
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$64.72
ALMRAlamar Biosciences, Inc. Common Stock	—	—	A	$33.02
CTKBCytek Biosciences, Inc. Common Stock	C	C	C	$4.58
PACBPacific Biosciences of California, Inc.	D	C	C	$1.52
MASS908 Devices Inc. Common Stock	C	C	A	$11.00
EYPTEyePoint, Inc. Common Stock	D	F	F	$5.00
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$23.25
LABStandard BioTools Inc. Common Stock	A	F	D	$0.65
QTRXQuanterix Corporation Common Stock	A	C	C	$2.79
SEERSeer, Inc. Class A Common Stock	C	D	C	$2.04
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.66
PRPOPrecipio, Inc. Common Stock	C	A	A	$30.85
HBIOHarvard Bioscience Inc	B	F	A	$7.58
ASTCAstrotech Corporation (DE) Common Stock	C	C	A	$7.10
BNGOBionano Genomics, Inc. Common Stock	A	C	C	$1.25
HLTHTema Healthcare AI ETF	—	F	D	$29.92
PRENWPrenetics Global Limited Warrant	—	—	D	$0.01

About Nautilus Biotechnolgy, Inc. Common Stock

Nautilus Biotechnology develops a platform technology for high-throughput proteomics analysis, providing researchers with integrated tools to study the human proteome at scale. The company's offerings include proprietary mass spectrometry systems, reagent kits, and analysis software designed for research, diagnostics, and drug development. As a development-stage company, Nautilus aims to expand access to comprehensive protein analysis and accelerate advances in human health and medicine.